<DOC>
	<DOCNO>NCT03004820</DOCNO>
	<brief_summary>This single-arm , open-labeled phase II futility study . Application Remote ischemic conditioning ( RIC ) adjunctive therapy medication involve study . The study test whether RIC effective prevent ischemic even minor ischemic stroke/transient ischemic attack within 3 month explore safety compliance chronic RIC . Medication strategy base physician 's best judgement .</brief_summary>
	<brief_title>Prevention Ischemic Conditions Non-disabling Stroke/Transient Ischemic Attack With Remote Ischemic Conditioning</brief_title>
	<detailed_description>This single-arm , open-labeled phase II futility study . Application Remote ischemic conditioning ( RIC ) adjunctive therapy medication involve study . RIC consist five cycle 5-min inflation ( 200 mmHg ) 5-min deflation cuff bilateral upper limb twice day . The study test whether RIC effective prevent ischemic even minor ischemic stroke/transient ischemic attack within 3 month explore safety compliance chronic RIC . Medication strategy base physician 's best judgement .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Ischemic Attack , Transient</mesh_term>
	<criteria>1 . Eighteen year old old gender race ; 2 . Diagnosed noncardiogenic MIS/TIA within 14 day ; MIS define ischemic stroke score 3 less NIHSS time inclusion , TIA define neurologic deficit attribute focal brain ischemia , symptom resolution within 24 h symptom onset , Symptom onset define `` last see normal '' principle ; 3 . Stable vital sign , normal cardiac , hepatic renal function ; 4 . Able consent himself/herself legally authorize representative . 1 . Diagnosis hemorrhage pathology , vascular malformation , tumor , abscess nonvascular disease , base brain CT MRI ; 2 . Modified Rankin Scale score &gt; 2 inclusion ; 3 . Received iv . recombinant tissue plasminogen activator ( rtPA ) therapy interventional treatment current event ; 4 . Contradiction aspirin clopidogrel ( know allergy , severe asthma heart failure et al . ) ; 5 . Clear indication anticoagulation therapy ( cardiac source embolus ) ; 6 . Hemorrhagic tendency reason （including limit Hemostatic disorder , platelet count &lt; 100 × 109/L , history druginduced hepatic dysfunction） ; 7 . Any hemorrhagic transformation ; 8 . Gastrointestinal bleed major surgery within 3 month symptoms onset ; 9 . Stroke TIA induce interventional therapy surgery ; 10 . Any upper extremity soft tissue , vascular injury peripheral blood vessel disease may contraindicate RIC ; 11 . Systolic blood pressure great 200 mmHg medication ; 12 . Planned revascularization ( angioplasty vascular surgery ) within next 3 month ； 13 . Scheduled surgery interventional treatment require RIC cessation within next 3 month ; 14 . Severe noncardiovascular comorbidity life expectancy &lt; 3 month ; 15 . Pregnancy ; 16 . Currently receive investigational drug device study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Minor Ischemic Stroke</keyword>
	<keyword>Transient Ischemic Attack</keyword>
	<keyword>Remote Ischemic Conditioning</keyword>
</DOC>